ctrl K

Foghorn Therapeutics Inc. (FHTX)

NASDAQ: FHTX · Real-Time Price · USD

4.25

0.09 (2.16%)

At close: May 02, 2025, 3:59 PM

4.24

-0.24%

After-hours: May 02, 2025, 04:05 PM EDT

Foghorn Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	22.6M	34.16M	19.23M	1.32M	430K	n/a	n/a
Cost of Revenue	3.12M	109.69M	19.23K	7.51M	57.72M	1.79M	379K
Gross Profit	19.48M	-75.53M	19.21M	-6.2M	-57.28M	-1.79M	-379K
Operating Income	-102.68M	-107.91M	-117.14M	-100.73M	-68.53M	-51.08M	-26.05M
Interest Income	11.9M	10.88M	5.67M	2.55M	1M	495K	113K
Pretax Income	-86.62M	-94.2M	-108.88M	-101.32M	-68.8M	-51.13M	-26.34M
Net Income	-86.62M	-98.43M	-108.87M	-103.23M	-69.78M	-51.67M	-26.34M
Selling & General & Admin	28.36M	32.37M	30.75M	21.73M	11.25M	6.72M	4.82M
Research & Development	94.53M	109.69M	105.62M	80.33M	57.72M	44.36M	21.23M
Other Expenses	2.4M	n/a	8.26M	2.49M	n/a	n/a	n/a
Operating Expenses	125.28M	142.06M	136.37M	102.05M	68.96M	51.08M	26.05M
Interest Expense	n/a	n/a	n/a	1.91M	979K	540K	371K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	125.28M	142.06M	136.37M	102.05M	68.96M	51.08M	26.05M
Income Tax Expense	n/a	4.23M	-8.26K	1.91M	979K	540K	83K
Shares Outstanding (Basic)	54.9M	41.97M	41.59M	37.17M	36.79M	36.82M	19.63M
Shares Outstanding (Diluted)	54.9M	41.97M	41.59M	37.17M	36.79M	36.82M	19.63M
EPS (Basic)	-1.58	-2.34	-2.62	-2.78	-1.9	-1.4	-1.34
EPS (Diluted)	-1.58	-2.34	-2.62	-2.78	-1.9	-1.4	-1.34
EBITDA	-97.17M	-104.45M	-113.82M	-96.19M	-66.49M	-48.8M	-25.59M
EBIT	-100.28M	-107.91M	-117.14M	-99.41M	-67.82M	-50.59M	-25.97M
Depreciation & Amortization	3.12M	3.45M	7.9M	7.51M	5.53M	1.79M	379K